Colorectal cancer screening stays in focus for adults 45 to 75

Colorectal cancer screening remains a practical preventive-care issue for many U.S. adults, especially people ages 45 to 75. The latest federal guidance continues to emphasize that screening is meant to look for cancer before symptoms start, when treatment may be easier and precancerous growths may still be removed.

That matters because the choice of test is not one-size-fits-all. Stool-based tests and colonoscopy can both play a role, but they differ in how often they are done, how much preparation they require, and whether a follow-up colonoscopy may be needed after an abnormal result.

Screening is different from checking symptoms

The CDC says cancer screening means checking for cancer before a person has symptoms. That is different from diagnostic testing, which is used when someone already has warning signs such as rectal bleeding, unexplained weight loss, a lasting change in bowel habits, or ongoing abdominal pain. People with symptoms should not treat screening advice as a substitute for medical evaluation.

The screening guidance discussed here is aimed at average-risk adults. People with a personal history of colorectal cancer or polyps, inflammatory bowel disease, or certain inherited syndromes may need a different plan.

Who should start, and when

For average-risk adults, routine colorectal cancer screening begins at age 45. This article focuses on the common screening window through age 75, which is the range most federal guidance highlights for routine screening decisions.

For adults near or above 75, the question often becomes less about following a standard schedule and more about weighing overall health, life expectancy, prior screening history, and the likelihood of benefit versus burden. That decision is best made with a clinician.

Common test options

In broad terms, screening choices fall into two groups:

Stool-based tests look for hidden blood or DNA markers in a stool sample. They are usually done at home and repeated on a schedule, but any positive result needs follow-up colonoscopy.
Colonoscopy lets a clinician look directly at the colon and remove polyps during the same procedure. It usually has a longer interval between tests, but it requires bowel prep, sedation, and time off for the procedure and recovery.

The practical tradeoff is convenience versus completeness. A stool test may be easier to complete, while colonoscopy can both detect and remove suspicious growths in one visit. Either way, the screening process is not finished unless abnormal findings are evaluated.

What newer evidence adds

Recent research continues to examine how long a negative colonoscopy result should be considered reassuring. A study published in JAMA Oncology found lower colorectal cancer incidence and mortality after a negative screening colonoscopy and suggested that rescreening intervals might be reconsidered for some low-risk people. The study adds useful context, but it does not change the fact that screening decisions still depend on a person’s risk profile, test quality, and follow-up history.

In plain language, the evidence supports a broader point: colonoscopy can provide long-lasting protection, but the right interval and the best test strategy are still being studied and debated. That is one reason guidelines and coverage policies continue to balance benefit, burden, and access.

Coverage and cost still matter

CMS says Medicare covers colorectal cancer screening as a preventive service, and the agency’s preventive-services materials list the screening tests available under Medicare. CMS also says many new private health plans must cover certain preventive services without cost-sharing when delivered by in-network providers.

Even so, readers should not assume every screening will be free in every situation. Plan rules, network status, test type, follow-up procedures, and billing details can affect what a person owes. A follow-up colonoscopy after an abnormal stool test may be handled differently from a routine screening colonoscopy, so it is worth checking coverage before the appointment.

What readers can do next

If you are between 45 and 75 and have not been screened, a reasonable next step is to ask your clinician which option best fits your age, risk factors, family history, and ability to complete follow-up care if a test is abnormal.

If you are already screening on schedule, keep the plan that was agreed on and make sure you know when your next test is due. If you are having symptoms, ask for a medical evaluation rather than assuming it is a screening issue.

For families and caregivers, the most helpful support may be practical: helping someone schedule the test, complete prep instructions, understand whether a stool kit needs to be mailed back, or confirm whether insurance covers the chosen option.

The bottom line is straightforward. Colorectal cancer screening is still one of the most useful preventive steps for U.S. adults ages 45 to 75, but the best test is the one a person can complete, follow through on, and discuss with a clinician in the context of their own risk.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.